A detailed history of Captrust Financial Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Captrust Financial Advisors holds 377,557 shares of ABT stock, worth $43.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
377,557
Previous 447,296 15.59%
Holding current value
$43.3 Million
Previous $46.5 Million 7.39%
% of portfolio
0.13%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $6.98 Million - $8.24 Million
-69,739 Reduced 15.59%
377,557 $43 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $708,937 - $791,352
-7,038 Reduced 1.55%
447,296 $46.5 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $1.41 Million - $1.55 Million
12,847 Added 2.91%
454,334 $51.6 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $5.61 Million - $6.86 Million
62,168 Added 16.39%
441,487 $48.6 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $1.57 Million - $1.89 Million
16,470 Added 4.54%
379,319 $36.7 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $1.23 Million - $1.37 Million
12,220 Added 3.49%
362,849 $39.6 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $928,403 - $1.09 Million
9,585 Added 2.81%
350,629 $35.5 Million
Q4 2022

Feb 15, 2023

BUY
$95.06 - $111.52 $449,063 - $526,820
4,724 Added 1.4%
341,044 $37.5 Million
Q3 2022

Nov 16, 2022

BUY
$96.76 - $112.03 $1.23 Million - $1.43 Million
12,742 Added 3.94%
336,320 $32.5 Million
Q2 2022

Aug 23, 2022

BUY
$102.07 - $123.37 $32.9 Million - $39.8 Million
322,378 Added 26864.83%
323,578 $35.2 Million
Q2 2022

Aug 16, 2022

SELL
$102.07 - $123.37 $29.6 Million - $35.7 Million
-289,739 Reduced 99.59%
1,200 $130,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $1.5 Million - $1.83 Million
13,129 Added 4.73%
290,939 $34.4 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $259,595 - $317,860
2,247 Added 0.82%
277,810 $39.1 Million
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $3.41 Million - $3.77 Million
29,240 Added 11.87%
275,563 $32.6 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $1.92 Million - $2.26 Million
18,184 Added 7.97%
246,323 $28.6 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $2.71 Million - $3.19 Million
24,915 Added 12.26%
228,139 $27.3 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $719,355 - $783,891
6,851 Added 3.49%
203,224 $22.3 Million
Q3 2020

Nov 17, 2020

SELL
$91.64 - $111.29 $1.2 Million - $1.45 Million
-13,046 Reduced 6.23%
196,373 $21.3 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $1.68 Million - $2.15 Million
21,987 Added 11.73%
209,419 $19.2 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $3.66 Million - $5.35 Million
-58,201 Reduced 23.69%
187,432 $14.4 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $10.7 Million - $11.9 Million
136,563 Added 125.21%
245,633 $21.4 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $93,706 - $101,607
1,145 Added 1.06%
109,070 $9.13 Million
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $3.35 Million - $3.91 Million
45,998 Added 74.28%
107,925 $9.08 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $94,760 - $114,565
1,431 Added 2.37%
61,927 $4.95 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $71,394 - $80,880
1,089 Added 1.83%
60,496 $4.38 Million
Q3 2018

Nov 15, 2018

BUY
$60.81 - $73.36 $1.35 Million - $1.63 Million
22,275 Added 59.99%
59,407 $4.36 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $127,920 - $141,185
2,222 Added 6.36%
37,132 $2.27 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $74,163 - $83,851
1,318 Added 3.92%
34,910 $2.03 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $1.58 Million - $1.69 Million
29,381 Added 697.72%
33,592 $1.92 Million
Q3 2017

Feb 16, 2018

BUY
$48.06 - $53.64 $202,380 - $225,878
4,211
4,211 $243,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.